Breaking news: Verrica announced the approval of YCANTH (cantharidin) topical solution 0.7%. Verrica Pharmaceuticals. Press release. July 21, 2023.
FDA approves VP-102 to treat molluscum contagiosum – Contemporary Pediatrics
Share This Story, Choose Your Platform!
About the Author:
